{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:47:12Z","timestamp":1793832432825,"version":"4.6.1"},"reference-count":70,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple myeloma (MM) initiation is dictated by genomic events. However, its progression from asymptomatic stages to an aggressive disease that ultimately fails to respond to treatments is also dependent on changes of the tumor microenvironment (TME). Clonal hematopoiesis of indeterminate potential (CHIP) is a prevalent clonal condition of the hematopoietic stem cell whose presence is causally linked to a more inflamed microenvironment. Here, we demonstrate in 106 patients with MM that CHIP is frequently coexisting with MM at diagnosis, associates with a more advanced Revised International Staging System stage and higher age, and has a nonsignificant trend toward lower median hemoglobin. In our cohort, the 2 conditions do not share a clonal origin. Single-cell RNA sequencing in 16 patients with MM highlights significant TME changes when CHIP is present: decreased naive T cells, a proinflammatory TME, decreased antigen-presenting function by dendritic cells, and expression of exhaustion markers in CD8 cells. Inferred interactions between cell types in CHIP-positive TME suggested that especially monocytes, T cells, and clonal plasma cells may have a prominent role in mediating inflammation, immune evasion, and pro-survival signals in favor of MM cells. Altogether, our data reveal that, in the presence of CHIP, the TME of MM at diagnosis is significantly disrupted in line with what is usually found in more advanced disease, with potential translational implications. Our data highlight the relevance of this association and prompt for further studies on the modifier role of CHIP in the MM TME.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024026236","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T18:24:33Z","timestamp":1742495073000},"page":"571-584","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-9095","authenticated-orcid":false,"given":"Marta","family":"Lionetti","sequence":"first","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Scopetti","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Matera","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4797-0314","authenticated-orcid":false,"given":"Akihiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Marella","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-7846","authenticated-orcid":false,"given":"Francesca","family":"Lazzaroni","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castellano","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1341-0503","authenticated-orcid":false,"given":"Sonia","family":"Fabris","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pioggia","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3034-9874","authenticated-orcid":false,"given":"Silvia","family":"Lonati","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Marchetti","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-6540","authenticated-orcid":false,"given":"Alessandra","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"3Flow Cytometry Laboratory, Clinical Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tornese","sequence":"additional","affiliation":[{"name":"3Flow Cytometry Laboratory, Clinical Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[{"name":"4Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8346-0826","authenticated-orcid":false,"given":"Claudia","family":"Leoni","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-2082","authenticated-orcid":false,"given":"Loredana","family":"Pettine","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5875-2623","authenticated-orcid":false,"given":"Valentina","family":"Traini","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Silvestris","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Barbieri","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Fabbiano","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4824-3445","authenticated-orcid":false,"given":"Domenica","family":"Ronchetti","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Taiana","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6583-6836","authenticated-orcid":false,"given":"Claudio","family":"De Magistris","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo C.","family":"Da Vi\u00e0","sequence":"additional","affiliation":[{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"},{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1018-5139","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Bolli","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy"},{"name":"2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2025073111222225700_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"2025073111222225700_bib2","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2025073111222225700_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jamaoncol.2019.4659","article-title":"Moving from cancer burden to cancer genomics for smoldering myeloma: a review","volume":"6","author":"Maura","year":"2020","journal-title":"JAMA Oncol"},{"issue":"6","key":"2025073111222225700_bib4","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1097\/HS9.0000000000000502","article-title":"A journey through myeloma evolution: from the normal plasma cell to disease complexity","volume":"4","author":"Da Vi\u00e0","year":"2020","journal-title":"HemaSphere"},{"issue":"1","key":"2025073111222225700_bib5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41467-021-22140-0","article-title":"Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities","volume":"12","author":"Oben","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2025073111222225700_bib6","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"Bolli","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"2025073111222225700_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"Das","year":"2016","journal-title":"Nat Med"},{"key":"2025073111222225700_bib8","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.15.593193","article-title":"A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma","author":"Pilcher","year":"17  2024","journal-title":"bioRxiv"},{"issue":"10","key":"2025073111222225700_bib9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1158\/2767-9764.CRC-22-0022","article-title":"Comprehensive characterization of the multiple myeloma immune microenvironment using integrated scRNA-seq, CyTOF, and CITE-seq analysis","volume":"2","author":"Yao","year":"2022","journal-title":"Cancer Res Commun"},{"issue":"3","key":"2025073111222225700_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-022-02178-3","article-title":"Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma","volume":"29","author":"Larrayoz","year":"2023","journal-title":"Nat Med"},{"issue":"5","key":"2025073111222225700_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","article-title":"Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma","volume":"1","author":"Zavidij","year":"2020","journal-title":"Nat Cancer"},{"issue":"26","key":"2025073111222225700_bib12","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"2025073111222225700_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood.2023019964","article-title":"The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia","volume":"143","author":"Fabre","year":"2024","journal-title":"Blood"},{"issue":"2","key":"2025073111222225700_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"2025073111222225700_bib15","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/2767-9764.CRC-23-0093","article-title":"Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma","volume":"3","author":"Mouhieddine","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"1","key":"2025073111222225700_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41375-021-01320-3","article-title":"Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length","volume":"36","author":"Boyle","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"2025073111222225700_bib17","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41375-018-0208-8","article-title":"Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation","volume":"32","author":"Chitre","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"2025073111222225700_bib18","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"2025073111222225700_bib19","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1002\/ajh.26125","article-title":"Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy","volume":"96","author":"Wudhikarn","year":"2021","journal-title":"Am J Hematol"},{"issue":"8","key":"2025073111222225700_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3390\/cells13080657","article-title":"Single-cell DNA sequencing reveals an evolutionary pattern of CHIP in transplant eligible multiple myeloma patients","volume":"13","author":"Borsi","year":"2024","journal-title":"Cells"},{"issue":"12","key":"2025073111222225700_bib21","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.3324\/haematol.2023.282992","article-title":"Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"issue":"3","key":"2025073111222225700_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bjh.18716","article-title":"Clonal haematopoiesis of indeterminate potential predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma","volume":"201","author":"Li","year":"2023","journal-title":"Br J Haematol"},{"issue":"16","key":"2025073111222225700_bib23","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood.2021014956","article-title":"Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms","volume":"140","author":"Sperling","year":"2022","journal-title":"Blood"},{"issue":"19","key":"2025073111222225700_bib24","first-page":"2359","article-title":"Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures","volume":"141","author":"Diamond","year":"2023","journal-title":"Blood"},{"issue":"21","key":"2025073111222225700_bib25","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1182\/bloodadvances.2021006498","article-title":"MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort","volume":"6","author":"Da Vi\u00e0","year":"2022","journal-title":"Blood Adv"},{"issue":"7","key":"2025073111222225700_bib26","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/bloodadvances.2021004926","article-title":"Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenstr\u00f6m macroglobulinemia","volume":"6","author":"Tahri","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"2025073111222225700_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood.2020007555","article-title":"Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder","volume":"137","author":"Klimkowska","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2025073111222225700_bib28","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"2025073111222225700_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.leu.2404616","article-title":"Transcriptional features of multiple myeloma patients with chromosome 1q gain","volume":"21","author":"Fabris","year":"2007","journal-title":"Leukemia"},{"issue":"22","key":"2025073111222225700_bib30","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2025073111222225700_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3324\/haematol.2014.113381","article-title":"Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol","volume":"100","author":"Bolli","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"2025073111222225700_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2015-11-683334","article-title":"Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies","volume":"128","author":"McKerrell","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2025073111222225700_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41408-019-0264-y","article-title":"Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. [published correction appears in Blood Cancer J. 2020;10(1):11]","volume":"9","author":"Yellapantula","year":"2019","journal-title":"Blood Cancer J"},{"issue":"24","key":"2025073111222225700_bib34","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.3390\/ijms232415691","article-title":"Single-cell RNA sequencing for the detection of clonotypic V(D)J rearrangements in multiple myeloma","volume":"23","author":"Matera","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2025073111222225700_bib35","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/bloodadvances.2023012409","article-title":"Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis","volume":"8","author":"Lazzaroni","year":"2024","journal-title":"Blood Adv"},{"key":"2025073111222225700_bib36","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2024025643","article-title":"Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma","author":"Da Vi\u00e1","year":"2025","journal-title":"Blood"},{"issue":"7","key":"2025073111222225700_bib37","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"2025073111222225700_bib38","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.13.544751","article-title":"MultiNicheNet: a flexible framework for differential cell-cell communication analysis from multi-sample multi-condition single-cell transcriptomics data","author":"Browaeys","year":"14  2023","journal-title":"bioRxiv"},{"issue":"1","key":"2025073111222225700_bib39","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat Commun"},{"issue":"10","key":"2025073111222225700_bib40","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41592-021-01274-5","article-title":"Systematic investigation of cytokine signaling activity at the tissue and single-cell levels","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat Methods"},{"issue":"3","key":"2025073111222225700_bib41","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3324\/haematol.2019.235424","article-title":"Differential RNA splicing as a potentially important driver mechanism in multiple myeloma","volume":"106","author":"Bauer","year":"2021","journal-title":"Haematologica"},{"issue":"23","key":"2025073111222225700_bib42","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1158\/1078-0432.CCR-15-1790","article-title":"The spectrum and clinical impact of epigenetic modifier mutations in myeloma","volume":"22","author":"Pawlyn","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2025073111222225700_bib43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"issue":"suppl 1","key":"2025073111222225700_bib44","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/blood-2022-168239","article-title":"TET2 down-regulation confers bortezomib resistance in multiple myeloma [abstract]","volume":"140","author":"Dai","year":"2022","journal-title":"Blood"},{"key":"2025073111222225700_bib45","doi-asserted-by":"crossref","first-page":"1059715","DOI":"10.3389\/fcell.2022.1059715","article-title":"Targeting TGF-\u03b2 signaling in the multiple myeloma microenvironment: steering CARs and T cells in the right direction","volume":"10","author":"Rana","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"2025073111222225700_bib46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00277-019-03648-4","article-title":"PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression","volume":"98","author":"Mussetti","year":"2019","journal-title":"Ann Hematol"},{"key":"2025073111222225700_bib47","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.3389\/fimmu.2018.02809","article-title":"The emerging role of CD244 signaling in immune cells of the tumor microenvironment","volume":"9","author":"Agresta","year":"2018","journal-title":"Front Immunol"},{"issue":"19","key":"2025073111222225700_bib48","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1111\/febs.15637","article-title":"The multifaceted role of TRAIL signaling in cancer and immunity","volume":"288","author":"Cardoso Alves","year":"2021","journal-title":"FEBS J"},{"issue":"5","key":"2025073111222225700_bib49","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI123955","article-title":"Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells","volume":"129","author":"Kamiya","year":"2019","journal-title":"J Clin Invest"},{"key":"2025073111222225700_bib50","doi-asserted-by":"crossref","first-page":"1077768","DOI":"10.3389\/fimmu.2022.1077768","article-title":"Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"2025073111222225700_bib51","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","article-title":"Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics","volume":"12","author":"Tirier","year":"2021","journal-title":"Nat Commun"},{"key":"2025073111222225700_bib52","doi-asserted-by":"crossref","first-page":"717998","DOI":"10.3389\/fimmu.2021.717998","article-title":"Leukocyte immunoglobulin-like receptors in regulating the immune response in infectious diseases: a window of opportunity to pathogen persistence and a sound target in therapeutics","volume":"12","author":"Abdallah","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"2025073111222225700_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood-2003-06-2043","article-title":"Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival","volume":"103","author":"Novak","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2025073111222225700_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijms19010089","article-title":"The dark side of IFN-\u03b3: its role in promoting cancer immunoevasion","volume":"19","author":"Mojic","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2025073111222225700_bib55","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2002-09-2813","article-title":"CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase\/AKT\/NF-kappa B signaling","volume":"101","author":"Tai","year":"2003","journal-title":"Blood"},{"key":"2025073111222225700_bib56","doi-asserted-by":"crossref","first-page":"215834","DOI":"10.1016\/j.canlet.2022.215834","article-title":"Single cell RNA-seq reveals the CCL5\/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer","volume":"545","author":"Chen","year":"2022","journal-title":"Cancer Lett"},{"key":"2025073111222225700_bib57","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.23.595594","article-title":"Clonal evolution of hematopoietic stem cells after cancer chemotherapy","author":"Uryu","year":"24  2024","journal-title":"bioRxiv"},{"issue":"24","key":"2025073111222225700_bib58","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.2020006540","article-title":"Cancer immunoediting and immune dysregulation in multiple myeloma","volume":"136","author":"Nakamura","year":"2020","journal-title":"Blood"},{"issue":"14","key":"2025073111222225700_bib59","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/bloodadvances.2023011445","article-title":"Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation","volume":"8","author":"Heimlich","year":"2024","journal-title":"Blood Adv"},{"issue":"4","key":"2025073111222225700_bib60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","article-title":"The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients","volume":"41","author":"Friedrich","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"2025073111222225700_bib61","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/bloodadvances.2023011225","article-title":"CD8 effector T cells enhance teclistamab response in BCMA-exposed and -na\u00efve multiple myeloma","volume":"8","author":"Firestone","year":"2024","journal-title":"Blood Adv"},{"issue":"9","key":"2025073111222225700_bib62","doi-asserted-by":"crossref","first-page":"927.e1","DOI":"10.1016\/j.jtct.2024.06.008","article-title":"Clonal hematopoiesis is associated with severe cytokine release syndrome in patients treated with chimeric antigen receptor T-cell (CART) therapy","volume":"30","author":"Goldsmith","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"2025073111222225700_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/2643-3230.BCD-21-0177","article-title":"Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma","volume":"3","author":"Saini","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"15","key":"2025073111222225700_bib64","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/bloodadvances.2021004554","article-title":"Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy","volume":"5","author":"Miller","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"2025073111222225700_bib65","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"issue":"7","key":"2025073111222225700_bib66","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/cas.15800","article-title":"Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma","volume":"114","author":"Jiang","year":"2023","journal-title":"Cancer Sci"},{"issue":"15","key":"2025073111222225700_bib67","doi-asserted-by":"crossref","first-page":"e167629","DOI":"10.1172\/JCI167629","article-title":"Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy","volume":"133","author":"Robinson","year":"2023","journal-title":"J Clin Invest"},{"issue":"22","key":"2025073111222225700_bib68","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1158\/1078-0432.CCR-23-2292","article-title":"Harnessing dendritic cells: next frontier for durable immune control in myeloma","volume":"29","author":"Dhodapkar","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025073111222225700_bib69","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.22.24309250","article-title":"Tumour-intrinsic features shape T-cell differentiation through myeloma disease evolution","author":"Foster","year":"12  2024","journal-title":"medRxiv"},{"issue":"8","key":"2025073111222225700_bib70","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.stem.2024.05.010","article-title":"Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging","volume":"31","author":"Jakobsen","year":"2024","journal-title":"Cell Stem Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/5\/571\/2404362\/blood_bld-2024-026236-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/5\/571\/2404362\/blood_bld-2024-026236-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:22:35Z","timestamp":1753975355000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/5\/571\/536243\/Clonal-hematopoiesis-is-clonally-unrelated-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024026236","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,31]]},"published":{"date-parts":[[2025,7,31]]}}}